Our Leadership Team
World-class experts driving innovation in biotechnology and pharmaceutical development. Our team brings together decades of experience from across the global healthcare landscape.
Dr. Thomas Mitchell
Chief Executive Officer
With over 20 years in biotechnology, Dr. Mitchell leads Tricida Pharma's strategic vision and global operations.
Dr. Michael Chen
Chief Scientific Officer
Dr. Chen oversees all research initiatives and has pioneered breakthrough gene therapy platforms.
Dr. Emily Rodriguez
VP of Clinical Development
Leading clinical trials worldwide, Dr. Rodriguez has successfully brought 30+ therapies to market.
James Patterson
Chief Financial Officer
James brings extensive financial expertise, driving sustainable growth and strategic partnerships.
Dr. Aisha Patel
Director of Gene Therapy
Dr. Patel leads our gene therapy division, focusing on rare genetic disorder treatments.
Advisory Board
Distinguished experts guiding our strategic direction
Dr. James Wilson
Medical Advisor
Former Chief Scientific Officer, PharmaTech Global
Dr. Linda Stevens
Regulatory Advisor
Former FDA Senior Policy Advisor
Dr. David Martinez
Innovation Advisor
MIT Professor of Biotechnology